Racial disparities in colorectal cancer survival: To what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics?

Cancer

Volumn 116, Issue 19, 2010, Pages 4622-4631

  White, Arica ^a   Vernon, Sally W ^a   Franzini, Luisa ^a   Du, Xianglin L ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Colorectal cancer; Disparities; Mortality; Race ethnicity; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COLORECTAL CANCER; COMORBIDITY; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIOECONOMICS; ASIAN CONTINENTAL ANCESTRY GROUP; BLACK PERSON; CAUCASIAN; COLORECTAL NEOPLASMS; ETHNOLOGY; HEALTH CARE DISPARITY; HEALTH DISPARITY; HISPANIC; HOSPITAL; MORTALITY; VERY ELDERLY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HOSPITALS; HUMANS; MALE; SEER PROGRAM; SOCIOECONOMIC FACTORS;

EID: 77957567369     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25395     Document Type: Article

References (53)

1. American Cancer Society. Cancer Facts and Figures 2009. Atlanta, Ga: American Cancer Society; 2009.
2. Le H, Ziogas A, Lipkin SM, et al. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev. 2008;17:1950-1962.
3. Du XL, Meyer TE, Franzini L. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer. 2007;109:2161-2170.
4. Chien C, Morimoto LM, Tom J, et al. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005;104:629-639.
5. Marcella S, Miller JE. Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol. 2001;54:359-366.
6. Doubeni CA, Field TS, Buist DS, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007;109:612-620.
7. Alexander D, Jhala N, Chatla C, et al. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer. 2005;103:2163-2170.
8. Chen VW, Fenoglio-Preiser CM, Wu XC, et al. Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6:1087-1093.
9. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
10. White A, Liu CC, Xia R, et al. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer. 2008;113:3400-3409.
11. Jessup JM, Stewart A, Greene FL, et al. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294:2703-2711.
12. Ellison GL, Warren JL, Knopf KB, et al. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res. 2003;38(6 pt 2):1885-1903.
13. Rolnick S, Hensley Alford S, Kucera GP, et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr. 2005;35:96-101.
14. Bach PB, Pham HH, Schrag D, et al. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351:575-584.
15. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst. 2001;93:501-515.
16. Birkmeyer NJ, Goodney PP, Stukel TA, et al. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer. 2005;103:435-441.
17. Paulson EC, Mitra N, Sonnad S, et al. National Cancer Institute designation predicts improved outcomes in colorectal cancer surgery. Ann Surg. 2008;248:675-686.
18. Roetzheim RG, Pal N, Gonzalez EC, et al. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health. 2000;90:1746-1754.
19. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 suppl):IV-3-IV-18.
20. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
21. US Census Bureau. How the Census Bureau Measures Poverty. Available at: http://www.census.gov/hhes/www/poverty/povdef.html. Accessed December 1, 2009.
22. Du XL, Fang S, Vernon SW, et al. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer. 2007;110:660-669.
23. Mandelblatt JS, Kerner JF, Hadley J, et al. Variations in breast carcinoma treatment in older Medicare beneficiaries: is it black or white? Cancer. 2002;95:1401-1414.
24. US Public Health Services. International Classification of Diseases, 9th Revision, Clinical Modification. 5th ed. Los Angeles, Calif: Practice Management Information Corporation; 1996.
25. American Medical Association. Physicians' Current Procedural Terminology - CPT 2000. Chicago, Ill: American Medical Association; 2000.
26. Health Care Financing Administration. HCFA Data Dictionary: Revenue Center Codes, Baltimore, Md: Health Care Financing Administration; 1999.
27. National Cancer Institute. Colon Cancer Treatment (PDQ). Available at: http://www.cancer.gov/cancertopics/pdq/treatment/colon/healthprofessional/. Accessed October 25, 2007.
28. National Cancer Institute. Rectal Cancer Treatment (PDQ). Available at: http://www.cancer.gov/cancertopics/pdq/treatment/rectal/healthprofessional. Accessed January 20, 2008.
29. National Cancer Institute. SEER-Medicare: Calculation of Comorbidity Weights. Available at: http://healthservices.cancer.gov/seermedicare/program/ comorbidity.html. Accessed March 10, 2009.
30. Du XL, Chan W, Giordano S, et al. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer. 2005;104:913-924.
31. Gross CP, Guo Z, McAvay GJ, et al. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2006;54:1898-1904.
32. Polednak AP. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006;30:466-472.
33. Le H, Ziogas A, Taylor TH, et al. Survival of distinct Asian groups among colorectal cancer cases in California. Cancer. 2008;115:259-270.
34. Sanoff HK, Sargent DJ, Green EM, et al. Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. J Clin Oncol. 2009;27:4109-4115.
35. Ashktorab H, Smoot DT, Farzanmehr H, et al. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer. 2005;116:914-919.
36. Carethers JM. Racial and ethnic factors in the genetic pathogenesis of colorectal cancer. J Assoc Acad Minor Phys. 1999;10:59-67.
37. Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology. 2004;126:394-401.
38. Singh GK, Miller BA. Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health. 2004;95:I14-I21.
39. Singh GK, Siahpush M. Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: an analysis of 2 national data bases. Hum Biol. 2002;74:83-109.
40. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006;24:3535-3541.
41. Powe BD. Cancer fatalism among elderly Caucasians and African Americans. Oncol Nurs Forum. 1995;22:1355-1359.
42. Wang JH, Liang W, Chen MY, et al. The influence of culture and cancer worry on colon cancer screening among older Chinese-American women. Ethn Dis. 2006;16:404-411.
43. Ball JK, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care. 1996;34:970-984.
44. Demissie K, Oluwole OO, Balasubramanian BA, et al. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between whites and blacks. Ann Epidemiol. 2004;14:215-221.
45. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348:1625-1638.
46. Dignam JJ, Polite BN, Yothers G. Effect of body mass index on outcomes in patients with Dukes B and C colon cancer: an analysis of NSABP randomized trials [abstract]. J Clin Oncol. 2005;23(16S). Abstract 3533.
47. Tomeo CA, Colditz GA, Willett WC, et al. Harvard Report on Cancer Prevention. Volume 3: prevention of colon cancer in the United States. Cancer Causes Control. 1999;10:167-180.
48. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
49. Pratt M, Macera CA, Blanton C. Levels of physical activity and inactivity in children and adults in the United States: current evidence and research issues. Med Sci Sports Exerc. 1999;31(11 suppl):S526-S533.
50. Iversen LH, Harling H, Laurberg S, et al. Influence of case-load and surgical specialty on outcome following surgery for colorectal cancer: a review of evidence. Part 2: long-term outcome. Colorectal Dis. 2007;9:38-46.
51. Morris AM, Wei Y, Birkmeyer NJ, et al. Racial disparities in late survival after rectal cancer surgery. J Am Coll Surg. 2006;203:787-794.
52. Du X, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of the linked Medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol. 1999;52:463-470.
53. Du X, Freeman JL, Warren JL, et al. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Med Care. 2000;38:719-727.